{
  "id": "0587eb573b2a9dab",
  "title": "Weekly Buzz : FDA OKs Roche Lunsumio VELO ; It No For Tolbrutinib ; BioMarin , Sanofi Open Wallets",
  "description": "20251226T160000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2025-12/67314063-weekly-buzz-fda-oks-roche-s-lunsumio-velo-it-s-no-for-tolbrutinib-biomarin-sanofi-open-wallets-020.htm",
  "published_at": "20251226T160000Z",
  "fetched_at": "2025-12-27T00:22:28.676313+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2025-12/67314063-weekly-buzz-fda-oks-roche-s-lunsumio-velo-it-s-no-for-tolbrutinib-biomarin-sanofi-open-wallets-020.htm",
    "url_mobile": "",
    "title": "Weekly Buzz : FDA OKs Roche Lunsumio VELO ; It No For Tolbrutinib ; BioMarin , Sanofi Open Wallets",
    "seendate": "20251226T160000Z",
    "socialimage": "https://www.finanznachrichten.de/chart-biomarin-pharmaceutical-inc-aktie-intraday-tradegate.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}